|Day Low/High||27.96 / 28.64|
|52 Wk Low/High||10.41 / 29.00|
That word of warning applies to ETFs and individual stocks such as Intercept Pharmaceuticals, which we outline a trading strategy for here.
This action is probably driven by the end of the year unwinding as well as concerns about weakness in bonds.
Peak says sell now or forever hold your peace because you can only go down from here.
We're going to see some random action in front of the weekend.
I've made a few buys but there just isn't much appetite for chasing strength right now.
We've got moves in AMC, GameStop and even Bed Bath & Beyond. But I'm playing Nokia and here's why.
Do you know what a company does, does it do it well, and is there anything going on that could change the trajectory?
I can't educate the foreign investors. The professional mutual fund managers think I'm dead wrong. But I can help teach the new retail traders.
The five best performing and worst performing stocks in the S&P 500 in the previous quarter pretty much tells the tale of the tape, so here goes.
I see a lot of winners here because of hindsight.
These are the stocks to watch as Iran production is called into question.
Action Alerts Plus portfolio manager and TheStreet's founder Jim Cramer insists investors to do their homework because Rule #4 of his 25 Investing Rules is to buy damaged stocks, not damaged companies. Watch now for more on how he made that mistake in the past!
Rev Shark is not convinced the market's action will be sustained.
These areas have little exposure to China, so buy them on any broad-market dip over U.S.-Chinese trade tensions.
How do we examine what might be attractive when the selling madness really abates?
It is fitting that the next leader of Berkshire will be either Jain or Abel.
Following up on my comments from earlier today, oil is below $43 a barrel and we're now starting to see the analyst community begin to downgrade stocks and start to trim back EPS expectations. Some of those on the receiving end here include Chevron ...